​
​

Entero Therapeutics Ownership 2024 | Who Owns Entero Therapeutics Now?

OverviewFinancialsChart
0

Entero Therapeutics Insider Shareholders Trades

Open Market Insider Trades

DateNameRelationRoleTransactionBuy/SellSharesPriceValueShares HeldSource
Jul 03, 2024Romano Sarahofficer Chief Financial OfficerS-SaleSell621$1.07$664.4718,490
Jul 03, 2024SAPIRSTEIN JAMESdirector, officer Chairman and CEOS-SaleSell1,289$1.07$1.38K35,816

Open Market Insider Buys

DateNameRelationRoleTransactionBuy/SellSharesPriceValueShares HeldSource

Insider Sells

DateNameRelationRoleTransactionBuy/SellSharesPriceValueShares HeldSource
Jul 03, 2024Romano Sarahofficer Chief Financial OfficerS-SaleSell621$1.07$664.4718,490
Jul 03, 2024SAPIRSTEIN JAMESdirector, officer Chairman and CEOS-SaleSell1,289$1.07$1.38K35,816

All Insider Owners Trades

DateNameRelationRoleTransactionBuy/SellSharesPriceValueShares HeldSource
Aug 14, 2024Ramdeen Timothy R.director Buy----
Jul 03, 2024Romano Sarahofficer Chief Financial OfficerS-SaleSell621$1.07$664.4718,490
Jul 03, 2024SAPIRSTEIN JAMESdirector, officer Chairman and CEOS-SaleSell1,289$1.07$1.38K35,816
Jun 12, 2024KHOSLA CHAITAN PHDdirector-A-AwardBuy24,889--24,889

The last insider sell of Entero Therapeutics's stock was made by Romano Sarah on Jul 03 2024, selling 621 shares at $1.07 per share (valued at $664.47).

Entero Therapeutics Insider Ownership Trends

All Insider Trades Trend

DateBuySellBuy/Sell Ratio
Q3 2024-2-
Q2 20241--

0 total buy trades, and 2 total sell trades (buy/sell ratio of 0.00%) were made by Entero Therapeutics's insiders, as of Q3 2024.

Open Market Insider Trades Trend

DateBuySellBuy/Sell Ratio
Q3 2024-2-
Q2 2024---

As of Q3 2024, Insider owners conducted 0 open market buy trades and 2 open market sell trades of Entero Therapeutics's stocks.

ENTO Ownership FAQ